Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | INPP5B | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
mRNA | PPP5C | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | PXN | CTRPv2 | pan-cancer | AAC | -0.18 | 2e-06 |
mRNA | LRRC34 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | UBTD1 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
mRNA | CBX2 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | PHIP | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | LUC7L | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | HAUS1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | ATG4C | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |